Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (71-80 of 662) with videos related to

Pageof 67
Sort By:
International Archives of Allergy and Immunology|March 29, 2002
Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosisWolfgang R Sperr, Hans-Peter Horny, Peter Valent
Oncotarget|October 22, 2014
Inhibition of STAT5: a therapeutic option in BCR-ABL1-driven leukemiaAngelika Berger, Veronika Sexl, Peter Valent, et al.
Deutsches Arzteblatt International|July 23, 2009
Mastocytosis: a disease of the hematopoietic stem cellHans-Peter Horny, Karl Sotlar, Peter Valent, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2022
Reply to "Need to define a subgroup of patients with idiopathic mast cell activation syndrome"Theo Gülen, Cem Akin, Dean D Metcalfe, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 12, 2022
Recent Developments in the Field of Mast Cell Disorders: Classification, Prognostication, and ManagementPeter Valent, Michel Arock, Cem Akin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 6, 2026
Reply to "Chronic Spontaneous Urticaria: The Most Common MCAS-Like Disease"Cem Akin, Theo Gülen, Mariana C Castells, et al.
International Archives of Allergy and Immunology|May 18, 2011
Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteriaPeter Valent, Hans-Peter Horny, Massimo Triggiani, et al.
Leukemia Research|August 23, 2005
Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosisHermine Agis, Karl Sotlar, Peter Valent, et al.
Leukemia Research|November 28, 2006
A patient with de novo AML M1 and t(16;21) with karyotype evolutionAndrea Zatkova, Christa Fonatsch, Wolfgang R Sperr, et al.
Expert Review of Hematology|July 16, 2014
Myelomastocytic leukemia: histopathological features, diagnostic criteria and differential diagnosisHans-Peter Horny, Karl Sotlar, Andreas Reiter, et al.
Pageof 67

Showing results (71-80 of 662) with videos related to

Sort By:
Pageof 67
International Archives of Allergy and Immunology|March 29, 2002
Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosisWolfgang R Sperr, Hans-Peter Horny, Peter Valent
Oncotarget|October 22, 2014
Inhibition of STAT5: a therapeutic option in BCR-ABL1-driven leukemiaAngelika Berger, Veronika Sexl, Peter Valent, et al.
Deutsches Arzteblatt International|July 23, 2009
Mastocytosis: a disease of the hematopoietic stem cellHans-Peter Horny, Karl Sotlar, Peter Valent, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2022
Reply to "Need to define a subgroup of patients with idiopathic mast cell activation syndrome"Theo Gülen, Cem Akin, Dean D Metcalfe, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 12, 2022
Recent Developments in the Field of Mast Cell Disorders: Classification, Prognostication, and ManagementPeter Valent, Michel Arock, Cem Akin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 6, 2026
Reply to "Chronic Spontaneous Urticaria: The Most Common MCAS-Like Disease"Cem Akin, Theo Gülen, Mariana C Castells, et al.
International Archives of Allergy and Immunology|May 18, 2011
Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteriaPeter Valent, Hans-Peter Horny, Massimo Triggiani, et al.
Leukemia Research|August 23, 2005
Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosisHermine Agis, Karl Sotlar, Peter Valent, et al.
Leukemia Research|November 28, 2006
A patient with de novo AML M1 and t(16;21) with karyotype evolutionAndrea Zatkova, Christa Fonatsch, Wolfgang R Sperr, et al.
Expert Review of Hematology|July 16, 2014
Myelomastocytic leukemia: histopathological features, diagnostic criteria and differential diagnosisHans-Peter Horny, Karl Sotlar, Andreas Reiter, et al.
Pageof 67